Dr. Michael Zelefsky is joining NYU L... - Prostate Cancer N...

Prostate Cancer Network

4,955 members3,087 posts

Dr. Michael Zelefsky is joining NYU Langone Medical Center

Hope4Happiness profile image
3 Replies

I received this message from Dr. Michael Zelefsky this month:

I’m writing this letter to let you know I will be leaving Memorial Sloan Kettering Cancer Center (MSK) on September 6, 2023. For more than 30 years, it has been an honor to be part of the care team at MSK. I will be making a change to lead the prostate cancer program at NYU Langone Medical Center’s cancer center.

There will be no change to your care at MSK. If you’re scheduled to see me after September 6, 2023, we will call you to reschedule your next appointment. Our excellent genitourinary oncology nurse practitioners will manage your care.

If you’re in active treatment, our nurse practitioners and Dr. Sean McBride or Dr. Marisa Kollmeier will continue your treatment plan. Our office will contact you with your next appointment.

As a member of the Department of Radiation Oncology, I had the good fortune to work with these wonderful colleagues at MSK. They’re all experts in prostate cancer.

I cannot praise this doctor enough. The care and treatment I received from him and his staff was outstanding. A fantastic benefit for NYU Langone and a great loss for MSKCC-NYC.

Written by
Hope4Happiness profile image
Hope4Happiness
To view profiles and participate in discussions please or .
Read more about...
3 Replies
Ahk1 profile image
Ahk1

He is a great doctor. I saw him twice.

Cooolone profile image
Cooolone

They all work as a team, so care won't be interrupted for sure. Dr. Kollmeier is excellent (personal experience) as well. Langone steals a good one ;)

bogiemooki profile image
bogiemooki

I wonder if there's a story behind it. Is it a simple matter of "they made him an offer he couldn't refuse"? I'm debating whether to follow him to NYU. As Coolone remarked, they work as a team. Dr. Zelefsky's nurse practitioner, Marie Nalle, was particularly fantastic during my treatment (started SBRT with a 6.33 PSA in May '22; PSA now 1.42). If Marie is still at MSK, I just may stay.

You may also like...

At NYU

had prostate cancer) had had an elevated PSA and was seeking care. He had discovered that MSKCC did

Update with genomic testing

forward now with treatment. The rest of my results are 5 core fragments out of 12 had cancer. Three...

Advanced PCa - medication side effects or brain mets?

diagnosed with relatively aggressive, stage 3 prostate cancer back in 2019, and he was responsive...

Envita Cancer center - Scotsdale

therapies to treat hormone sensitive Stage 4 Prostate Cancer

New here and need recommendations

still just in the Prostate. Other stats are 33cc volume, Oncotype DX genomic prostate score of 19...